Neurones (0GX2) Ratios
Neurones Ratios
GB:0GX2's free cash flow for Q2 2026 was $25.13M. For the 2026 fiscal year, GB:0GX2's free cash flow was decreased by $-8.54M and operating cash flow was $33.66M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 2.43 | 2.33 | 2.38 | 2.45 | 2.51 |
| Quick Ratio | 2.43 | 2.33 | 2.38 | 2.44 | 2.51 |
| Cash Ratio | 1.36 | 1.29 | 1.30 | 1.31 | 1.44 |
| Solvency Ratio | 0.25 | 0.21 | 0.25 | 0.25 | 0.24 |
| Operating Cash Flow Ratio | 0.32 | 0.33 | 0.31 | 0.27 | 0.35 |
| Short-Term Operating Cash Flow Coverage | 24.06 | 17.16 | 12.35 | 361.43 | 315.53 |
| Net Current Asset Value | $ 324.37M | $ 298.60M | $ 279.47M | $ 265.94M | $ 249.22M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.05 | 0.06 | 0.07 | 0.06 | 0.06 |
| Debt-to-Equity Ratio | 0.09 | 0.11 | 0.12 | 0.11 | 0.11 |
| Debt-to-Capital Ratio | 0.08 | 0.10 | 0.11 | 0.10 | 0.10 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.87 | 1.92 | 1.90 | 1.86 | 1.82 |
| Debt Service Coverage Ratio | 15.28 | 9.30 | 10.24 | 36.46 | 49.03 |
| Interest Coverage Ratio | 60.43 | 47.36 | 52.90 | 42.80 | 63.74 |
| Debt to Market Cap | 0.00 | 0.01 | 0.01 | 0.00 | 0.00 |
| Interest Debt Per Share | 1.32 | 1.80 | 1.87 | 1.54 | 1.50 |
| Net Debt to EBITDA | -3.36 | -3.31 | -2.63 | -2.67 | -3.02 |
| Profitability Margins | |||||
| Gross Profit Margin | 10.50% | 47.97% | 46.78% | 12.27% | 12.03% |
| EBIT Margin | 8.44% | 9.61% | 10.89% | 11.02% | 10.63% |
| EBITDA Margin | 10.54% | 10.60% | 13.04% | 13.33% | 13.15% |
| Operating Profit Margin | 8.44% | 9.61% | 10.23% | 10.96% | 10.62% |
| Pretax Profit Margin | 9.64% | 10.87% | 10.90% | 10.95% | 10.65% |
| Net Profit Margin | 6.07% | 6.48% | 6.67% | 6.65% | 6.50% |
| Continuous Operations Profit Margin | 7.22% | 7.80% | 7.90% | 7.78% | 7.40% |
| Net Income Per EBT | 63.04% | 59.59% | 61.18% | 60.72% | 61.05% |
| EBT Per EBIT | 114.20% | 113.09% | 106.47% | 99.96% | 100.30% |
| Return on Assets (ROA) | 6.95% | 7.23% | 7.33% | 7.18% | 6.64% |
| Return on Equity (ROE) | 13.02% | 13.89% | 13.94% | 13.38% | 12.10% |
| Return on Capital Employed (ROCE) | 14.50% | 16.47% | 17.03% | 17.82% | 16.07% |
| Return on Invested Capital (ROIC) | 10.62% | 11.51% | 12.00% | 12.41% | 10.96% |
| Return on Tangible Assets | 7.59% | 7.87% | 7.95% | 7.76% | 7.22% |
| Earnings Yield | 4.18% | 4.92% | 4.66% | 4.65% | 4.10% |
| Efficiency Ratios | |||||
| Receivables Turnover | 3.91 | 3.74 | 3.57 | 3.46 | 3.50 |
| Payables Turnover | 12.94 | 7.23 | 8.96 | 13.60 | 13.52 |
| Inventory Turnover | 42618.50 | 1579.00 | 556.30 | 1653.67 | 575.13 |
| Fixed Asset Turnover | 14.44 | 13.39 | 12.62 | 13.64 | 12.58 |
| Asset Turnover | 1.14 | 1.12 | 1.10 | 1.08 | 1.02 |
| Working Capital Turnover Ratio | 2.47 | 2.48 | 2.41 | 2.30 | 2.04 |
| Cash Conversion Cycle | 65.21 | 47.38 | 62.10 | 78.83 | 77.91 |
| Days of Sales Outstanding | 93.40 | 97.65 | 102.20 | 105.45 | 104.27 |
| Days of Inventory Outstanding | 0.01 | 0.23 | 0.66 | 0.22 | 0.63 |
| Days of Payables Outstanding | 28.20 | 50.50 | 40.76 | 26.84 | 26.99 |
| Operating Cycle | 93.41 | 97.88 | 102.86 | 105.67 | 104.91 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 2.79 | 3.48 | 2.97 | 2.27 | 2.67 |
| Free Cash Flow Per Share | 2.43 | 2.98 | 2.23 | 1.83 | 2.40 |
| Dividend Paid and CapEx Coverage Ratio | 1.92 | 2.05 | 1.61 | 1.58 | 1.18 |
| Capital Expenditure Coverage Ratio | 7.74 | 7.01 | 4.01 | 5.18 | 9.83 |
| Operating Cash Flow Coverage Ratio | 2.19 | 2.01 | 1.64 | 1.54 | 1.83 |
| Operating Cash Flow to Sales Ratio | 0.09 | 0.10 | 0.10 | 0.08 | 0.11 |
| Free Cash Flow Yield | 5.65% | 6.78% | 5.10% | 4.66% | 6.31% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 20.12 | 20.25 | 21.46 | 21.49 | 24.40 |
| Price-to-Sales (P/S) Ratio | 1.45 | 1.32 | 1.43 | 1.43 | 1.59 |
| Price-to-Book (P/B) Ratio | 3.11 | 2.82 | 2.99 | 2.88 | 2.95 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 17.69 | 14.75 | 19.60 | 21.45 | 15.84 |
| Price-to-Operating Cash Flow Ratio | 15.41 | 12.64 | 14.71 | 17.31 | 14.23 |
| Price-to-Earnings Growth (PEG) Ratio | -14.55 | 2.94 | 1.96 | 1.24 | 1.07 |
| Enterprise Value Multiple | 10.41 | 9.10 | 8.35 | 8.05 | 9.06 |
| Enterprise Value | 940.54M | 782.29M | 806.64M | 714.26M | 690.34M |
| EV to EBITDA | 10.41 | 9.10 | 8.35 | 8.05 | 9.06 |
| EV to Sales | 1.10 | 0.97 | 1.09 | 1.07 | 1.19 |
| EV to Free Cash Flow | 13.37 | 10.81 | 14.91 | 16.11 | 11.88 |
| EV to Operating Cash Flow | 11.64 | 9.27 | 11.19 | 13.00 | 10.67 |
| Tangible Book Value Per Share | 13.91 | 15.57 | 14.65 | 13.60 | 12.68 |
| Shareholders’ Equity Per Share | 13.84 | 15.58 | 14.62 | 13.65 | 12.87 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.25 | 0.28 | 0.27 | 0.29 | 0.30 |
| Revenue Per Share | 29.66 | 33.39 | 30.58 | 27.47 | 23.95 |
| Net Income Per Share | 1.80 | 2.16 | 2.04 | 1.83 | 1.56 |
| Tax Burden | 0.63 | 0.60 | 0.61 | 0.61 | 0.61 |
| Interest Burden | 1.14 | 1.13 | 1.00 | 0.99 | 1.00 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.00 | 0.38 | 0.00 | 0.00 | 0.29 |
| Stock-Based Compensation to Revenue | 0.00 | 0.01 | 0.01 | 0.01 | 0.00 |
| Income Quality | 1.55 | 1.33 | 1.23 | 1.24 | 1.72 |
Currency in EUR